These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8892767)

  • 1. Attenuation of the no-reflow phenomenon after coronary angioplasty for acute myocardial infarction with intracoronary papaverine.
    Ishihara M; Sato H; Tateishi H; Kawagoe T; Shimatani Y; Kurisu S; Sakai K
    Am Heart J; 1996 Nov; 132(5):959-63. PubMed ID: 8892767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction.
    Morishima I; Sone T; Okumura K; Tsuboi H; Kondo J; Mukawa H; Matsui H; Toki Y; Ito T; Hayakawa T
    J Am Coll Cardiol; 2000 Oct; 36(4):1202-9. PubMed ID: 11028471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction.
    Taniyama Y; Ito H; Iwakura K; Masuyama T; Hori M; Takiuchi S; Nishikawa N; Higashino Y; Fujii K; Minamino T
    J Am Coll Cardiol; 1997 Nov; 30(5):1193-9. PubMed ID: 9350914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between attenuated plaque identified by intravascular ultrasound and no-reflow after stenting in acute myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.
    Wu X; Mintz GS; Xu K; Lansky AJ; Witzenbichler B; Guagliumi G; Brodie B; Kellett MA; Dressler O; Parise H; Mehran R; Stone GW; Maehara A
    JACC Cardiovasc Interv; 2011 May; 4(5):495-502. PubMed ID: 21596321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of angiographic (TIMI grade) blood flow by intracoronary Doppler flow velocity during acute myocardial infarction.
    Kern MJ; Moore JA; Aguirre FV; Bach RG; Caracciolo EA; Wolford T; Khoury AF; Mechem C; Donohue TJ
    Circulation; 1996 Oct; 94(7):1545-52. PubMed ID: 8840842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of reactive hyperemia after coronary recanalization on myocardial tissue reperfusion by thrombolysis in myocardial infarction flow grade in acute myocardial infarction.
    Okamura A; Ito H; Iwakura K; Kawano S; Kurotobi T; Date M; Inoue K; Ogihara T; Fujii K
    Am J Cardiol; 2006 Mar; 97(5):617-23. PubMed ID: 16490424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracoronary verapamil for reversal of no-reflow during coronary angioplasty for acute myocardial infarction.
    Werner GS; Lang K; Kuehnert H; Figulla HR
    Catheter Cardiovasc Interv; 2002 Dec; 57(4):444-51. PubMed ID: 12455077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of PercuSurge device conjugative with intracoronary administration of nitroprusside on no-reflow phenomenon following primary percutaneous coronary intervention.
    Youssef AA; Wu CJ; Hang CL; Cheng CI; Yang CH; Chen CJ; Chen YH; Chai HT; Chua S; Yeh KH; Yip HK
    Circ J; 2006 Dec; 70(12):1538-42. PubMed ID: 17127795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of intracoronary diltiazem on no-reflow phenomenon after emergent percutaneous coronary intervention in patients with acute myocardial infarction].
    Zheng ZF; Pu XQ; Yang TL; Li CC; Peng DD; Yu ZX; Mo L; Chen XB
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Dec; 31(6):917-20. PubMed ID: 17213597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of no-reflow phenomenon observed on angiography after successful treatment of acute myocardial infarction with percutaneous transluminal coronary angioplasty.
    Morishima I; Sone T; Mokuno S; Taga S; Shimauchi A; Oki Y; Kondo J; Tsuboi H; Sassa H
    Am Heart J; 1995 Aug; 130(2):239-43. PubMed ID: 7631601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intracoronary administration of anisodamine on slow reflow phenomenon following primary percutaneous coronary intervention in patients with acute myocardial infarction.
    Fu XH; Fan WZ; Gu XS; Wei YY; Jiang YF; Wu WL; Li SQ; Hao GZ; Wei QM; Xue L
    Chin Med J (Engl); 2007 Jul; 120(14):1226-31. PubMed ID: 17697572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Coronary flow after successful angioplasty in patients with acute myocardial infarction: comparison between coronary flow reserve by nicorandil and papaverine].
    Izumi C; Kondo H; Tamura T; Inoko M; Kitaguchi S; Hirozane T; Himura Y; Iga K; Gen H; Konishi T
    J Cardiol; 2000 Mar; 35(3):175-80. PubMed ID: 10808424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative estimation of myocardial salvage after primary percutaneous transluminal coronary angioplasty in patients with angiographic no reflow.
    Nakamura S; Takehana K; Sugiura T; Hatada K; Hamada S; Asada J; Yuyama R; Mimura J; Imuro Y; Kurihara H; Fukui M; Baden M; Iwasaka T
    Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):383-9. PubMed ID: 12634966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pressure-derived collateral flow index as a parameter of microvascular dysfunction in acute myocardial infarction.
    Yamamoto K; Ito H; Iwakura K; Shintani Y; Masuyama T; Hori M; Kawano S; Higashino Y; Fujii K
    J Am Coll Cardiol; 2001 Nov; 38(5):1383-9. PubMed ID: 11691512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET perfusion and vasodilator function after angioplasty for acute myocardial infarction.
    Stewart RE; Miller DD; Bowers TR; McCullough PA; Ponto RA; Grines CL; O'Neill WW; Juni JE; Safian RD
    J Nucl Med; 1997 May; 38(5):770-7. PubMed ID: 9170444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective intracoronary administration of nitroprusside before balloon dilatation prevents slow reflow during percutaneous coronary intervention in patients with acute myocardial infarction.
    Shinozaki N; Ichinose H; Yahikozawa K; Shimada H; Hoshino K
    Int Heart J; 2007 Jul; 48(4):423-33. PubMed ID: 17827814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of no-reflow phenomenon with verapamil after primary stent deployment during myocardial infarction.
    Demir I; Yilmaz H; Ermis C; Sancaktar O
    Jpn Heart J; 2002 Nov; 43(6):573-80. PubMed ID: 12558122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of no-reflow phenomenon after successful percutaneous coronary intervention in patients with acute myocardial infarction: intravascular ultrasound findings.
    Watanabe T; Nanto S; Uematsu M; Ohara T; Morozumi T; Kotani J; Nishio M; Awata M; Nagata S; Hori M
    Circ J; 2003 Aug; 67(8):667-71. PubMed ID: 12890907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention.
    Resnic FS; Wainstein M; Lee MK; Behrendt D; Wainstein RV; Ohno-Machado L; Kirshenbaum JM; Rogers CD; Popma JJ; Piana R
    Am Heart J; 2003 Jan; 145(1):42-6. PubMed ID: 12514653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of no-reflow and impaired flow with the nitric oxide donor nitroprusside following percutaneous coronary interventions: initial human clinical experience.
    Hillegass WB; Dean NA; Liao L; Rhinehart RG; Myers PR
    J Am Coll Cardiol; 2001 Apr; 37(5):1335-43. PubMed ID: 11300444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.